suvizumab (102)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

QVQLVQSGAE VKKPGASVKV SCKASGYTFT NSWIGWFRQA PGQGLEWIGD  50

IYPGGGYTNY NEIFKGKATM TADTSTNTAY MELSSLRSED TAVYYCSRGI 100

PGYAMDYWGQ GTLVTVSSAS TKGPSVFPLA PSSKSTSGGT AALGCLVKDY 150

FPEPVTVSWN SGALTSGVHT FPAVLQSSGL YSLSSVVTVP SSSLGTQTYI 200

CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPELLGGPS VFLFPPKPKD 250

TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST 300

YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY 350

TLPPSRDELT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD 400

SDGSFFLYSK LTVDKSRWQQ GNVFSCSVMH EALHNHYTQK SLSLSPGK   448

Light chain / Chaone lygire / Cadena ligera

DIQMTQRPDS LSASVGDRVT MSCKSSQSLL NSGDQKNYLT WYQQKPGQPP  50

KLLIYWASTG ESGVPDRFSG SGSGTDFTFT ISSLQPEDIA TYYCQNDYSY 100

PWTFGQGTKV EIKRTVAAPS VFIFPPSDEQ LKSGTASVVC LLNNFYPREA 150

KVQWKVDNAL QSGNSQESVT EQDSKDSTYS LSSTLTLSKA DYEKHKVYAC 200

EVTHQGLSSP VTKSFNRGEC                                  220

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	21-96	145-201	262-322	368-426

	21??-96??	145??-201??	262??-322??	368??-426??

Intra-L	23?-94?	140?-200?



	23???-94???	140???-200???



Inter-H-L	221-220?	221??-220???



Inter-H-H	227-227??	230-230??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

298, 298??

CAS		914257-21-9 

Description

immunoglobulin G1-kappa, anti-[human immunodeficiency virus type 1
(HIV-1) envelope glycoprotein gp120 third variable loop V3], humanized
monoclonal antibody;

gamma1 heavy chain (1-448) [humanized VH (Homo sapiens IGHV1-46*01
(77.60%) -(IGHD)-IGHJ4*01) [8.8.11] (1-118) -Homo sapiens IGHG1*01
(119-448)], (221-220?)-disulfide with kappa light chain (1'-220')
[humanized V-KAPPA (Homo sapiens IGKV4-1*01 (77.20%) -IGKJ1*01) [12.3.9]
(1?-113?) -Homo sapiens IGKC*01 (114?-220?)];
(227-227":230-230")-bisdisulfide dimer

immunoglobuline G1-kappa, anti-[troisiime boucle variable V3 de la
glycoprotyine d'enveloppe gp120 du virus type 1 de l'immunodyficience
humaine (VIH-1)], anticorps monoclonal humanisy; 

chaone lourde gamma1 (1-448) [VH humanisy (Homo sapiens IGHV1-46*01
(77.60%) -(IGHD)-IGHJ4*01) [8.8.11] (1-118) -Homo sapiens IGHG1*01
(119-448)], (221-220?)-disulfure avec la chaone lygire kappa (1'-220')
[V-KAPPA humanisy (Homo sapiens IGKV4-1*01 (77.20%) -IGKJ1*01) [12.3.9]
(1?-113?) -Homo sapiens IGKC*01 (114?-220?)]; dimire
(227-227":230-230")-bisdisulfure 

inmunoglobulina G1-kappa, anti-[tercer bucle variable V3 de la
glicoprotenna de la envoltura gp120 del virus tipo 1 de la
inmunodeficiencia humana (VIH-1)], anticuerpo monoclonal humanizado; 

cadena pesada gamma1 (1-448) [VH humanizado(Homo sapiens IGHV1-46*01
(77.60%) -(IGHD)-IGHJ4*01) [8.8.11] (1-118) -Homo sapiens IGHG1*01
(119-448)], (221-220?)-disulfuro con la cadena  ligera kappa (1?-220?)
[V-KAPPA humanizada (Homo sapiens IGKV4-1*01 (77.20%) -IGKJ1*01)
[12.3.9] (1?-113?) -Homo sapiens IGKC*01 (114?-220?)]; dnmero
bisdisulfuro-(227-227":230-230")

	

WHO 

International Nonproprietary Names Programme	

15/01/2010

9185



		

